Evaluation of the effects of human leukocyte IFN-α on the immune response to the HBV vaccine in healthy unvaccinated individuals (Q56790230)

Marina Selleri

20

0 references

Carmela Cursaro

Carmela Cursaro

12

0 references

Maria E. Tosti

Maria Elena Tosti

8

0 references

Pietro Andreone

Pietro Andreone

Maria Rosaria Capobianchi

15

0 references

Maria Capobianchi

22

0 references

Filippo Belardelli

Filippo Belardelli

23

0 references

Persephone Borrow

Persephone Borrow

19

0 references

Concetta Castilletti

21

Concetta Castilletti

0 references

author name string

Imerio Capone

2

0 references

Francesca Urbani

3

0 references

Enrica Montefiore

4

0 references

Maria Rapicetta

5

0 references

Paola Chionne

6

0 references

Angela Candido

7

0 references

Maria Grimaldi

9

0 references

Ernesto Palazzini

10

0 references

Giuseppe Viscomi

11

0 references

Marzia Margotti

13

0 references

Alessandra Scuteri

14

0 references

Elisabeth Taylor

16

0 references

Elisabeth A. Haygreen

17

0 references

David F. Tough

Global control of hepatitis B virus infection.

18

0 references

language of work or name

English

0 references

publication date

February 2008

0 references

published in

Vaccine

0 references

volume

26

0 references

page(s)

1038-1049

0 references

issue

8

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Advances in vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Cytokines as natural adjuvants for vaccines: where are we now?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Cytokines as a link between innate and adaptive antitumor immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Type I interferon as a link between innate and adaptive immunity through dendritic cell stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Interferon-alpha in tumor immunity and immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

A New Type I IFN-Mediated Pathway for the Rapid Differentiation of Monocytes into Highly Active Dendritic Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Monocyte-derived dendritic cells generated after a short-term culture with IFN-alpha and granulocyte-macrophage colony-stimulating factor stimulate a potent Epstein-Barr virus-specific CD8+ T cell response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Expression of CCR-7, MIP-3beta , and Th-1 chemokines in type I IFN-induced monocyte-derived dendritic cells: importance for the rapid acquisition of potent migratory and functional activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Potent immune response against HIV-1 and protection from virus challenge in hu-PBL-SCID mice immunized with inactivated virus-pulsed dendritic cells generated in the presence of IFN-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Interferon as an adjuvant for hepatitis B vaccination in non- and low-responder populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Randomized comparative trial of interferon-alpha versus placebo in hepatitis B vaccine non-responders and hyporesponders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Host genotype influences immunomodulation by interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination of healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

The use of Flt3 ligand as an adjuvant for hepatitis B vaccination of healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044

Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.12.044